The objectives of this research program are 1) to define the neurological mechanisms operating at the hypothalamic level to control vasopressin (VP) release and 2) to ascertain the relationship of these control mechanisms to the osmotic regulation of VP release. Two culture systems will be used in these studies: organ cultured explants of the adult rat hypothalamo-neurohypophyseal system (HNS) and primary dispersed monolayer co-cultures of anterior hypothalamus (including the supraoptic nucleus) with either pituicytes or ventral medullary neurons (including the Al catecholamine neurons.) The effect of various agents on VP release from these cultures will be monitored with a VP radioimmunoassay. Norepinephrine release from the dispersed cultures containing Al neurons will be monitored with HPLC techniques. Specific agents to be evaluated are neurotransmitters, centrally active brain peptides, prostaglandins, and agents used clinically in the treatment of abnormalities of VP release. These studies will provide information on the mechanisms which allow a single target neuron to integrate multiple afferent signals. They will also provide basic information about the physiological mechanisms involved in the osmotic control of VP release, and thereby, they may provide the basis for understanding clinically observed abnormalities in VP release.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM019761-09
Application #
3151251
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1977-05-01
Project End
1987-03-31
Budget Start
1985-08-01
Budget End
1987-03-31
Support Year
9
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
Schools of Medicine
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Clough, R W; Hoffman, G E; Sladek, C D (1990) Synergistic interaction between opioid receptor blockade and alpha-adrenergic stimulation on luteinizing hormone-releasing hormone (LHRH) secretion in vitro. Neuroendocrinology 51:131-8
Elfont, R M; Sundaresan, P R; Sladek, C D (1989) Adrenergic receptors on cerebral microvessels: pericyte contribution. Am J Physiol 256:R224-30
Clough, R W; Hoffman, G E; Sladek, C D (1988) Peripubertal development of noradrenergic stimulation of luteinizing hormone-releasing hormone neurosecretion in vitro. Brain Res 446:121-32
Earnest, D J; Sladek, C D (1987) Circadian vasopressin release from perifused rat suprachiasmatic explants in vitro: effects of acute stimulation. Brain Res 422:398-402
Sladek, C D; Armstrong, W E (1987) gamma-Aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants. Endocrinology 120:1576-80
Davis, B J; Blair, M L; Sladek Jr, J R et al. (1987) Effects of lesions of hypothalamic catecholamines on blood pressure, fluid balance, vasopressin and renin in the rat. Brain Res 405:1-15
Clough, R W; Aravich, P F; Sladek, C D (1986) Monosodium glutamate neurotoxicity: a sex-specific impairment of blood pressure but not vasopressin in developing rats. Brain Res Bull 17:51-8
Earnest, D J; Sladek, C D (1986) Circadian rhythms of vasopressin release from individual rat suprachiasmatic explants in vitro. Brain Res 382:129-33
Herman, J P; Sladek, C D; Hansen, C T et al. (1986) Characterization of a new rodent model of diabetes insipidus: the Roman high avoidance rat homozygous for diabetes insipidus. Neuroendocrinology 43:340-7
Armstrong, W E; Gallagher, M J; Sladek, C D (1986) Noradrenergic stimulation of supraoptic neuronal activity and vasopressin release in vitro: mediation by an alpha 1-receptor. Brain Res 365:192-7

Showing the most recent 10 out of 13 publications